Startups
A cloud based/ AI-driven software for single cell RNA sequencing (scRNA-seq) cancer test analysis for complementary diagnostics in cytopathology: A Tool Maximizing Presurgical Diagnosis • High resolution tumor classification: classification of subclones at cell level • New tumor biological pathway detection • Molecular subtype inference at cytopathology (pre surgery) stage; currently only histological way (post-surgery) exists. • Cancer origin tracking: primary, metastasis, organ • Integration of single nucleotide variants & gene copy number variants for genetic mutation identification • First-in/ best-in drug discovery
Overview
Location
United States, California, Berkeley
Employees
1-10
Founded date
2023
FAQ about WittGen Biotechnologies
When was WittGen Biotechnologies founded?
WittGen Biotechnologies was founded in 2023.
Is WittGen Biotechnologies still active?
Yes, WittGen Biotechnologies is active.